GSMA
6.6.2018 10:02:09 CEST | Business Wire | Press release
As part of its role within the W20 (Women 20) group1 , the GSMA has backed a series of recommendations to promote digital inclusion for women to be presented to the G20 member states later this year. The GSMA is Topic Chair of the Digital Inclusion theme within the W20, which is advising the G20 on issues around gender equality and the economic empowerment of women, supporting the Sustainable Development Goals (SDGs), particularly SDG #5 (Gender Equality).
“The GSMA has been privileged to help shape the W20 recommendations, which will provide an actionable roadmap for the G20 nations to drive gender equality policies around the world,” said Mats Granryd, Director General of the GSMA. “These recommendations underline the importance of closing the digital gender gap by removing barriers to access and use, and promoting policies that encourage the digital inclusion of women. We believe this approach will ensure women and girls play a major role in shaping our future digital economies.”
“Ensuring that women are digitally included brings significant benefits for them and for their communities and economies”, added Susana Balbo, Chair of the W20.
At a W20 roundtable in Paris last week, the GSMA chaired the debate between the W20 delegates to set the Digital Inclusion recommendations. There are four agreed recommendations that call on G20 member states to:
1) Collect, track and analyse data on women’s access to and use of digital technologies and on the presence of women in STEM-related courses, careers and in leadership positions;
2) Develop holistic policies that focus on the barriers to women’s access to and use of digital technologies including accessibility, affordability, safety and security, digital skills and availability of relevant content and services;
3) Promote initiatives that drive equal participation of women and girls in STEM studies and digital-intensive work to ensure that women participate and lead in the design, development and governance of digital technologies, as well as entrepreneurs in the digital sector;
4) Ensure that all analyses of the future of work, including education needs and demands for new skills, are performed with a view to gender balance, social protection and job quality.
These recommendations feed into what will be presented at the G20 Argentina 2018 summit taking place in Buenos Aires, 30 November – 1 December 2018, where the G20 governments will be asked to make concrete commitments on each issue.
Mobile Industry Supporting Digital Inclusion for Women
The
GSMA is committed to supporting increased digital and financial
inclusion for women, reflecting the fact that mobile is the primary way
for people to access the internet in many parts of the world. However,
according to the latest GSMA research2
, women in low- and
middle-income countries are 26 percent less likely than men to use
mobile internet.
As part of the GSMA’s Connected Women initiative, 36 mobile operators across Africa, Asia and Latin America have made 51 formal commitments to reduce the gender gap in their mobile money or mobile internet customer base, driving an effort to accelerate digital and financial inclusion for women. To date, the Connected Women programme and its mobile operator partners have delivered life-enhancing services to more than 22 million women.
As well as the Connected Women programme and its participation in W20 , the GSMA also supports efforts to accelerate digital and financial inclusion for women via its participation in W20 ; the EQUALS initiative; the GSMA Connected Women programme; Women4Tech ; the WeCare initiative in Latin America; and the #BetterFuture campaign.
-ENDS-
About the GSMA
The GSMA represents the interests of mobile
operators worldwide, uniting nearly 800 operators with more than 300
companies in the broader mobile ecosystem, including handset and device
makers, software companies, equipment providers and internet companies,
as well as organisations in adjacent industry sectors. The GSMA also
produces industry-leading events such as Mobile World Congress, Mobile
World Congress Shanghai, Mobile World Congress Americas and the Mobile
360 Series of conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA .
________________________
1
The W20 is one of seven
independent engagement groups comprised of civil society organisations
from the G20 member counties. The engagement groups convene in tandem
with the G20 and ensure that the position of civil society on important
issues is taken on board by the G20 leaders. For more information see http://w20argentina.com
2
https://www.gsma.com/mobilefordevelopment/programmes/connected-women/the-mobile-gender-gap-report-2018
View source version on businesswire.com: https://www.businesswire.com/news/home/20180606005078/en/
Contact:
For the GSMA
Beau Bass
+44 79 7662 4962
beau.bass@webershandwick.com
or
GSMA
Press Office
pressoffice@gsma.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy8.6.2026 12:00:00 CEST | Press release
Shilpa Biocare Pvt Ltd, a Subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED) has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeutics. Shilpa becomes a strategic shareholder and CMC, manufacturing, and regulatory partner for G2B-002 — Gate2Brain's lead program targeting deadly pediatric brain cancers, DIPG and pGBM, both with Orphan Drug Designation from the US FDA and EMA. G2B-002 uses Gate2Brain's proprietary MiniAp4 peptide shuttle to deliver SN-38 across the blood-brain barrier, demonstrating up to 100-fold greater brain drug transport preclinically. First-in-human trials are anticipated by FY28. G2B-002 targets high-growth oncology markets — the glioblastoma market projected at USD 6.48B by 2035 (CAGR: 7.97%), pediatric brain tumors at USD 2.47B by 2031 (CAGR: 6.9%), and DIPG at USD 1.2B by 2035 (CAGR: 7.1%). Gate2Brain's MiniAp4 platform further extends potential across rare pediatric cancers and broader CNS cat
Haleon Invests in India to Deliver Better Everyday Health to Rural Communities8.6.2026 11:11:00 CEST | Press release
£175m for first Haleon manufacturing site in Madhya Pradesh, central IndiaFast-growing India key to Haleon reaching one billion more consumers by 2030India’s consumer health market to reach over £23bn by 20301Accelerated rural distribution to access 3 million outletsAffordable Sensodyne packs and investment to double ‘last-mile’ reach in rural areas Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million2 in building a new oral health manufacturing site in Madhya Pradesh, central India and accelerate distribution efforts in rural India to meet rising demand. The new site will also support supply for wider Asia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608753094/e
Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-18.6.2026 10:56:00 CEST | Press release
Oraglutide™ Once Weekly, Low Dose, Low side-effect, Oral GLP-1 Glucose and Insulin Response Over 6 days: Clinical Data Posted at World ADA Diabetes & Obesity Conference Diabetology Limited (Jersey) poster presentation (https://diabetology.co.uk/ada-poster) 1724-P at the ADA 86th Scientific Session, New Orleans, reporting first human data from Oraglutide™ — small capsule intestinally-released oral semaglutide, formulated using the proprietary Axcess™ delivery technology. KEY HIGHLIGHTS 6-day glucose control: A single 4 mg oral dose of Oraglutide™ produced a sustained fall in glucose. Measuring 14% at Day 6 (p=.046), the longest duration presented from a single oral GLP-1 dose in a human IVGTT study. 28% increase in insulin secretion: Relative to placebo, insulin percent AUC increased by 12% day 0, (p=0.02) & 28% Day 1 (p = 0.025). Novel intestinal depot effect: Blood levels of semaglutide were higher on Day 1 than dosing on Day 0, consistent with lipid associated depot effect in the int
Reply at VivaTech 2026: Making AI, Agents and Robotics Happen Across the Enterprise8.6.2026 10:00:00 CEST | Press release
Reply[EXM, STAR: REY] is taking part in VivaTech 2026, Europe's largest innovation and technology event, held from June 17 to 20 at Paris Expo Porte de Versailles. At the event, Reply will showcase its latest innovations around AI for software engineering, AI-powered experiences, data and AI, and industrial AI. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608667672/en/ At VivaTech 2026 Reply will showcase its latest innovations around AI for software engineering, AI-powered experiences, data and AI, and industrial AI. Industries are being reshaped by AI, autonomous agents, robotics and new digital experiences. From strategy to execution, Reply helps companies move beyond experimentation and innovative ideas into concrete business value. Visitors can meet Reply in Hall 7.1, booth 1G12, and explore how, through real use cases, scalable solutions and live demonstrations, the group makes innovation happen. This year, Reply'
Cardiolife Partners with Bhutan Ministry of Health to Strengthen Nationwide Cardiac Care8.6.2026 10:00:00 CEST | Press release
Cardiolife is proud to partner with the Ministry of Health of Bhutan to roll out its advanced AI-powered ECG diagnostics system nationwide. The collaboration will provide access to early ECG diagnosis and prevention, marking a major step forward in the country’s effort to strengthen heart health and preventive care. Bhutan has a population of just over 700,000 people and heart failure and other cardiac conditionsare among the leading causes of death. Following constructive meetings in Thimphu, His Excellency, the Health Minister, officially endorsed the national rollout of Cardiolife’s solution and expressed appreciation for Cardiolife’s commitment to advancing cardiac care through the provision of free software and ECG equipment in Bhutan. “We are grateful to the Cardiolife team for their commitment to improving heart health in Bhutan. With cardiovascular diseases on the rise, this collaboration marks an important milestone in our journey to strengthen early detection and prevention a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
